Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis.

Mahmoud Nassar Hazem Maarouf Abosheaishaa Awadhesh Kumar Singh Anoop MisraZachary Bloomgarden

Published in: Journal of diabetes (2023)

AGM use was not associated with increased mortality. However, metformin and GLP-1RA use reduced mortality risk statistically significantly. DPP-4i use was associated with a statistically significant increase in the risk of hospitalization and admission to the ICU.

Keyphrases

coronavirus disease
sars cov
intensive care unit
emergency department
rheumatoid arthritis
cardiovascular events
mechanical ventilation
risk factors
disease activity
ankylosing spondylitis
cardiovascular disease
interstitial lung disease
acute respiratory distress syndrome
extracorporeal membrane oxygenation